Literature DB >> 24041474

Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160Δc(BaL.).

Christian Gaebler1, Henning Gruell, Klara Velinzon, Johannes F Scheid, Michel C Nussenzweig, Florian Klein.   

Abstract

Significant efforts have been made to identify HIV-1 neutralizing antibodies because they are considered to be critical to the design of an effective HIV-1 vaccine. Although soluble HIV-1 envelope proteins can be used for this purpose, these reagents differ from membrane-anchored HIV-1 envelope spike in a number of important ways and display only a subset of its native epitopes. Consistent with this, some broadly neutralizing antibodies preferentially bind cell surface-expressed HIV-1 envelope, but not the soluble protein. Here we report the details of a new method for isolating anti-HIV-1 specific B cells based on capturing cells that produce antibodies to cell surface-expressed gp160Δc(BaL). While this method is far less efficient than sorting with soluble envelope proteins, it isolated broadly neutralizing anti-HIV-1 antibodies that bind cell surface-expressed gp160Δc(BaL) but not soluble envelope proteins.
© 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV-1; HIV-1 neutralizing antibodies; Single B cell sort; Surface-expressed envelope trimer

Mesh:

Substances:

Year:  2013        PMID: 24041474      PMCID: PMC3854001          DOI: 10.1016/j.jim.2013.09.003

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  49 in total

1.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

Authors:  Johannes F Scheid; Hugo Mouquet; Beatrix Ueberheide; Ron Diskin; Florian Klein; Thiago Y K Oliveira; John Pietzsch; David Fenyo; Alexander Abadir; Klara Velinzon; Arlene Hurley; Sunnie Myung; Farid Boulad; Pascal Poignard; Dennis R Burton; Florencia Pereyra; David D Ho; Bruce D Walker; Michael S Seaman; Pamela J Bjorkman; Brian T Chait; Michel C Nussenzweig
Journal:  Science       Date:  2011-07-14       Impact factor: 47.728

3.  Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.

Authors:  Ema T Crooks; Tommy Tong; Keiko Osawa; James M Binley
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

4.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Albert Cupo; Charles D Murin; Ronald Derking; Simon Hoffenberg; Michael J Caulfield; C Richter King; Andre J Marozsan; Per Johan Klasse; Rogier W Sanders; John P Moore; Ian A Wilson; Andrew B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

5.  Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.

Authors:  D M Callewaert; G Radcliff; R Waite; J LeFevre; M D Poulik
Journal:  Cytometry       Date:  1991

6.  Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

Authors:  Penny L Moore; Emma T Crooks; Lauren Porter; Ping Zhu; Charmagne S Cayanan; Henry Grise; Paul Corcoran; Michael B Zwick; Michael Franti; Lynn Morris; Kenneth H Roux; Dennis R Burton; James M Binley
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Authors:  Laura M Walker; Sanjay K Phogat; Po-Ying Chan-Hui; Denise Wagner; Pham Phung; Julie L Goss; Terri Wrin; Melissa D Simek; Steven Fling; Jennifer L Mitcham; Jennifer K Lehrman; Frances H Priddy; Ole A Olsen; Steven M Frey; Phillip W Hammond; Stephen Kaminsky; Timothy Zamb; Matthew Moyle; Wayne C Koff; Pascal Poignard; Dennis R Burton
Journal:  Science       Date:  2009-09-03       Impact factor: 47.728

8.  Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4.

Authors:  James E Robinson; Kelly Franco; Debra Holton Elliott; Mary Jane Maher; Ashley Reyna; David C Montefiori; Susan Zolla-Pazner; Miroslaw K Gorny; Zane Kraft; Leonidas Stamatatos
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

9.  Increasing the potency and breadth of an HIV antibody by using structure-based rational design.

Authors:  Ron Diskin; Johannes F Scheid; Paola M Marcovecchio; Anthony P West; Florian Klein; Han Gao; Priyanthi N P Gnanapragasam; Alexander Abadir; Michael S Seaman; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

Review 10.  Neutralizing antibodies to HIV-1 induced by immunization.

Authors:  Laura E McCoy; Robin A Weiss
Journal:  J Exp Med       Date:  2013-02-11       Impact factor: 14.307

View more
  6 in total

1.  Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.

Authors:  Devin Sok; Marit J van Gils; Matthias Pauthner; Jean-Philippe Julien; Karen L Saye-Francisco; Jessica Hsueh; Bryan Briney; Jeong Hyun Lee; Khoa M Le; Peter S Lee; Yuanzi Hua; Michael S Seaman; John P Moore; Andrew B Ward; Ian A Wilson; Rogier W Sanders; Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 2.  Progress in HIV-1 vaccine development.

Authors:  Barton F Haynes; M Anthony Moody; Munir Alam; Mattia Bonsignori; Laurent Verkoczy; Guido Ferrari; Feng Gao; Georgia D Tomaras; Hua-Xin Liao; Garnett Kelsoe
Journal:  J Allergy Clin Immunol       Date:  2014-06-26       Impact factor: 10.793

3.  Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.

Authors:  Habtom H Habte; Saikat Banerjee; Heliang Shi; Yali Qin; Michael W Cho
Journal:  Virology       Date:  2015-10-09       Impact factor: 3.616

Review 4.  Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.

Authors:  Lutz Gieselmann; Christoph Kreer; Meryem Seda Ercanoglu; Nathalie Lehnen; Matthias Zehner; Philipp Schommers; Julian Potthoff; Henning Gruell; Florian Klein
Journal:  Nat Protoc       Date:  2021-05-25       Impact factor: 13.491

Review 5.  Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies.

Authors:  Jorge Carrillo; Bonaventura Clotet; Julià Blanco
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

Review 6.  Techniques to Study Antigen-Specific B Cell Responses.

Authors:  Jim Boonyaratanakornkit; Justin J Taylor
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.